Snowball logo
logo
3970

Aprilbio Co. Ltd.

397030 KQ
28,900.00+400.00  (1.4%)
Estimate
Beta
1.661
Growth
Revenue, YoY
-66.6%
Net income, YoY
-66.14%
FCF, YoY
-60.48%
Forecast
EPS (FWD)
-955
About the company
Ticker
397030
ISIN
Country
South Korea
Sector (GICS)
Energy
AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

Frequently asked questions

What sector does Aprilbio Co. Ltd. (397030) operate in?

Aprilbio Co. Ltd. belongs to the Energy sector and operates in the Biotechnology industry.

What is Aprilbio Co. Ltd. (397030) current stock price?

As of the latest data, Aprilbio Co. Ltd. stock price is ₩28,900, with a previous close of ₩28,500. Aprilbio Co. Ltd. gained ₩400 in the last trading session, representing a 1.4% increase.

What is Aprilbio Co. Ltd. (397030) current market capitalization?

Aprilbio Co. Ltd. market cap is approximately 674.60 billion.

Does Aprilbio Co. Ltd. (397030) pay dividends?

No. Aprilbio Co. Ltd. does not pay a dividend.

What is Aprilbio Co. Ltd. (397030) beta (volatility) score?

Aprilbio Co. Ltd. has a beta of 1.661, suggesting it is more volatile than the market.